| Patent application number | Description | Published |
|---|
| 20090030050 | Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use - Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 01-29-2009 |
| 20090181966 | PGD2 receptor antagonists for the treatment of inflammatory diseases - Disclosed herein are compounds represented by Structural Formula (I) and (I-A): | 07-16-2009 |
| 20090312375 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE - Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 12-17-2009 |
| 20100076030 | METHODS OF TREATING RHEUMATOID ARTHRITIS - Imidazole-based compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 03-25-2010 |
| 20100234356 | COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS - The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: | 09-16-2010 |
| 20100249174 | CCR1 ANTAGONISTS AND METHODS OF USE THEREFOR - The invention provides compounds having the formula: | 09-30-2010 |
| 20110082178 | METHODS OF TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES AND DISORDERS - Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 04-07-2011 |
